The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan

Semin Thromb Hemost. 1999;25(5):487-9. doi: 10.1055/s-2007-994955.

Abstract

Recent studies in Caucasian populations have shown an association of the Leiden mutation in factor V with preeclampsia (PE). It consists of a substitution of a G (G1691) with an A (A1691) at nucleotide position 1691 in exon 10, resulting in arginine instead of glutamine at residue 506 at the factor V cleavage site for activated protein C (APC); it contributes to the resistance to APC. The purpose of this study was to determine whether the Leiden mutation is associated with pregnancy-induced hypertension (PIH), including PE, in Japanese women. We examined the genotypes of factor V of 71 Japanese patients with PIH and 109 controls. None of the 180 Japanese women carried the factor V Leiden mutation. To date, the factor V Leiden mutation is rare and not a common cause of PIH in Japan. The results may suggest that there is a significant ethnic difference in the role of the Leiden mutation in compounding the risk factors in the pathogenesis of PIH between Japanese and Caucasian populations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activated Protein C Resistance
  • Adult
  • Factor V / genetics*
  • Family Health
  • Female
  • Genotype
  • Humans
  • Japan / epidemiology
  • Point Mutation
  • Pre-Eclampsia / epidemiology
  • Pre-Eclampsia / etiology*
  • Pre-Eclampsia / genetics*
  • Pregnancy
  • Retrospective Studies

Substances

  • factor V Leiden
  • Factor V